1. Home
  2. NC vs BIOA Comparison

NC vs BIOA Comparison

Compare NC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

HOLD

Current Price

$55.03

Market Cap

412.1M

Sector

Energy

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$20.04

Market Cap

443.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NC
BIOA
Founded
1913
2015
Country
United States
United States
Employees
1700
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
412.1M
443.9M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
NC
BIOA
Price
$55.03
$20.04
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$33.33
AVG Volume (30 Days)
9.3K
1.0M
Earning Date
03-04-2026
03-19-2026
Dividend Yield
1.83%
N/A
EPS Growth
N/A
N/A
EPS
3.88
N/A
Revenue
$280,838,000.00
$5,917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.23
N/A
Revenue Growth
25.35
N/A
52 Week Low
$30.00
$2.88
52 Week High
$56.00
$24.00

Technical Indicators

Market Signals
Indicator
NC
BIOA
Relative Strength Index (RSI) 71.83 61.85
Support Level $46.55 $18.70
Resistance Level $50.00 $20.66
Average True Range (ATR) 1.90 1.43
MACD 0.84 -0.22
Stochastic Oscillator 88.34 33.10

Price Performance

Historical Comparison
NC
BIOA

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: